urea has been researched along with Takotsubo Cardiomyopathy in 3 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Takotsubo Cardiomyopathy: A transient left ventricular apical dysfunction or ballooning accompanied by electrocardiographic (ECG) T wave inversions. This abnormality is associated with high levels of CATECHOLAMINES, either administered or endogenously secreted from a tumor or during extreme stress.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawano, H | 2 |
| Yamasa, T | 2 |
| Arakawa, S | 2 |
| Matsumoto, Y | 2 |
| Sato, O | 2 |
| Maemura, K | 2 |
| Madias, JE | 1 |
3 other studies available for urea and Takotsubo Cardiomyopathy
| Article | Year |
|---|---|
Landiolol dramatically improved Takotsubo cardiomyopathy in an older patient.
Topics: Aged; Humans; Morpholines; Takotsubo Cardiomyopathy; Treatment Outcome; Urea | 2017 |
Cardioselective ultra-short-acting β-blockers for patients with Takotsubo syndrome?
Topics: Adrenergic beta-1 Receptor Antagonists; Humans; Morpholines; Takotsubo Cardiomyopathy; Urea | 2018 |
We need more useful surrogate markers for the efficacy of beta-blockers for the treatment of Takotsubo cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Female; Hum | 2018 |